UNSPSC 51262506: Guanazodine sulfate monohydrate

This classification denotes an alpha-adrenergic agonist with the molecular formula C9H20N4.H2O.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UKI3DAO4S6. The term guanazodine sulfate is a U.S. FDA designation. Most nations, for tariff and trade purposes, schedule guanazodine sulfate monohydrate under HS 29339990. As of Q4 2014, GUANAZODINE SULFATE MONOHYDRATE remains US FDA's Preferred Term for this commodity. Guanazodine sulfate monohydrate bears US NLM identifiers UMLS ID C2827164 and NCI Concept Code C83742.

SMILES: C1CCCNC(CC1)CNC(=N)N.O.OS(=O)(=O)O.

UNSPSC 51262506 Guanazodine sulfate monohydrate is a Commodity code that shows a significant mismatch between its nominal scope and actual state and local procurement activity. The recent opportunities tagged to this code involve naloxone distribution and pharmaceutical prescription programs — neither of which align with guanazodine sulfate monohydrate, a chemical compound used in veterinary and research applications. State and local governments are not currently soliciting guanazodine sulfate monohydrate under this code. The issuing bodies in the available records are a county health department and a state health and human services agency, both pursuing pharmaceutical and naloxone-related services that fall outside the chemical's intended use case.

Activity appears concentrated in the Southeast and Texas. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a response deadline of July 26, 2023 (note: the posted date of June 30, 2026 conflicts with the stated deadline of July 26, 2023 in the source). The Texas Health and Human Services Commission issued an RFI on April 3, 2026 to gather vendor capabilities for a direct-to-manufacturer prescription program aimed at improving pharmacy benefit management outside traditional PBM and group purchasing organization channels. Neither opportunity reflects genuine demand for guanazodine sulfate monohydrate, suggesting this code assignment is likely a data-entry error in the state procurement systems rather than evidence of active market demand for the chemical itself.